Shapiro S, Kohn D, Gershon H
Department of Immunology, Rappaport Faculty of Medicine, Israel Institute of Technology, Haifa.
Br J Haematol. 1993 Apr;83(4):648-54. doi: 10.1111/j.1365-2141.1993.tb04705.x.
Erythrocytes from elderly donors (> 70 years), but not young donors (18-35 years), are shown to undergo sequestration in an in vitro erythrophagocytosis assay. Comparable levels of sequestration are observed for high density erythrocytes from young individuals and both low density and high density erythrocytes from elderly individuals. These cells, which are susceptible to phagocytosis with no additional treatment are collectively termed 'in situ aged' erythrocytes. We present evidence for the involvement of complement in the sequestration of 'in situ aged' erythrocytes and correlate levels of complement bound to 'in situ aged' erythrocytes from young and elderly donors with levels of phagocytosis. We also demonstrate that the in vitro sequestration of erythrocytes from elderly donors can be inhibited by beta-galactosyl sugars and arginine-glycine-aspartic acid (RGD) but not by mannose nor by Protein-G, a specific inhibitor of Fc-gamma mediated phagocytosis. These experiments show that IgG is not the major opsonin in the sequestration of red cells from elderly donors. In support of the role of complement rather than IgG as the major opsonin in red cell sequestration, we further demonstrate that C'3 bearing immune complexes block in vitro sequestration of erythrocytes from elderly donors. This competition is not dependent upon the isotype of the immunoglobulin (IgM or IgG) in the complex but rather on the presence of active complement.
在体外红细胞吞噬试验中,来自老年供体(>70岁)的红细胞会发生隔离,而来自年轻供体(18 - 35岁)的红细胞则不会。对于来自年轻人的高密度红细胞以及来自老年人的低密度和高密度红细胞,观察到了相当程度的隔离现象。这些未经额外处理就易被吞噬的细胞被统称为“原位老化”红细胞。我们提供了补体参与“原位老化”红细胞隔离的证据,并将与来自年轻和老年供体的“原位老化”红细胞结合的补体水平与吞噬水平相关联。我们还证明,来自老年供体的红细胞在体外的隔离可被β - 半乳糖基糖和精氨酸 - 甘氨酸 - 天冬氨酸(RGD)抑制,但不能被甘露糖或Fc - γ介导吞噬作用的特异性抑制剂Protein - G抑制。这些实验表明,IgG不是老年供体红细胞隔离中的主要调理素。为支持补体而非IgG作为红细胞隔离中主要调理素的作用,我们进一步证明携带C'3的免疫复合物可阻断来自老年供体红细胞的体外隔离。这种竞争不依赖于复合物中免疫球蛋白的同种型(IgM或IgG),而是取决于活性补体的存在。